Keyphrases
Effectiveness Evaluation
100%
Propranolol
100%
Infantile Hemangioma
100%
Response to Treatment
25%
Best Response
25%
Partial Response
25%
Effective Treatment
12%
Response Predictors
12%
Response to Therapy
12%
Tertiary Care Hospital
12%
Clinical Data
12%
Epidemiological Data
12%
Tumors in children
12%
No Response
12%
Safety Profile
12%
Time-to-treatment
12%
Poor Response
12%
Clinical Safety
12%
Clinical Efficacy
12%
Treatment Initiation
12%
Age at Treatment
12%
Treatment Information
12%
Irritation
12%
Involution
12%
Vascular Tumor
12%
Systemic Side Effects
12%
Redness
12%
Topical Therapy
12%
Pediatric Dermatology
12%
Local Side Effects
12%
Topical beta-blocker
12%
Superficial Infantile Hemangioma
12%
Medicine and Dentistry
Propranolol
100%
Capillary Hemangioma
100%
Retrospective Study
22%
Adverse Event
11%
Beta Adrenergic Receptor Blocking Agent
11%
Side Effect
11%
Vascular Tissue Neoplasm
11%
Topical Treatment
11%
Involution
11%
Pediatric Dermatology
11%
Pharmacology, Toxicology and Pharmaceutical Science
Propranolol
100%
Capillary Hemangioma
100%
Retrospective Study
22%
Side Effect
11%
Adverse Event
11%
Beta Adrenergic Receptor Blocking Agent
11%
Vascular Tumor
11%